Cigna Holding Form 4 CIGNA / Jason D Sadler ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sadler Jason D

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CIGNA CORP [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Pres., International Markets

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.25 Par Value	08/07/2017		M		13,340	A	$78.035	47,844	D
Common Stock, $.25 Par Value	08/07/2017		M		10,534	A	$120.895	58,378	D
Common Stock, $.25 Par Value	08/07/2017		M		4,864	A	$58.73	63,242	D
Common Stock, $.25 Par Value	08/07/2017		M		4,562	A	$139.22	67,804	D
Common Stock, $.25 Par Value	08/07/2017		S		37,756	D	$176.1574(1)	30,048	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$120.895	08/07/2017		M			10,534	02/25/2016(2)	02/25/2025	Common Stock, $.25 Par Value	10,534	$0.0000	5,268	D
Employee Stock Option (Right to Buy)	$78.035	08/07/2017		M			13,340	02/26/2015(3)	02/26/2024	Common Stock, $.25 Par Value	13,340	$0.0000	0.0000	D
Employee Stock Option (Right to Buy)	$139.22	08/07/2017		M			4,562	03/01/2017(4)	03/01/2026	Common Stock, $.25 Par Value	4,562	$0.0000	9,124	D
Employee Stock Option (Right to Buy)	$58.73	08/07/2017		M			4,864	03/05/2014(5)	03/05/2023	Common Stock, $.25 Par Value	4,864	$0.0000	0.0000	D

Explanation of Responses:

1. Represents the weighted average price of the shares sold. The prices actually received ranged from $175.89 to $176.44 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

2. This option vests in three equal annual installments. The first installment became exercisable on February 25, 2016, the second installment became exercisable on February 25, 2017, and the last installment becomes exercisable on February 25, 2018.

3. This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

4. This option vests in three equal annual installments. The first installment became exercisable on March 1, 2017, and the next two installments become exercisable on March 1, 2018 and March 1, 2019.

5. This option was granted on March 5, 2013. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

	By: Jill M. Stadelman, attorney-in-fact	08/09/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.